Triple probe FISH approach for detecting EML4-ALK gene rearrangement in Chinese patients with NSCLC

被引:0
|
作者
Mao, Weimin
Han, Mark
Ling, Zhiqiang
Sun, Wenyong
Zhang, Gu
Dong, Hongshan
Zhang, Yingzi
机构
[1] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[2] GeneDiagnost Inc, Hangzhou, Zhejiang, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e21080
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Deciphering Evolution of Targeted Therapy Resistance in EML4-ALK NSCLC
    Marusyk, A.
    Vander Velde, R.
    Marusyk, V.
    Peacock, J.
    Kenian, L.
    Haura, E.
    Scott, J.
    Marusyk, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (08) : S1547 - S1547
  • [22] A case of primary pulmonary atypical carcinoid with EML4-ALK rearrangement
    Liu, Na
    Wang, Jingjing
    Fu, Xiao
    Zheng, Xiaoqiang
    Gao, Huan
    Tian, Tao
    Ruan, Zhiping
    Yao, Yu
    CANCER BIOLOGY & THERAPY, 2020, 21 (01) : 12 - 16
  • [23] Endobronchial Metastases in Lung Cancer Harboring EML4-ALK Rearrangement
    Ijichi, Miharu
    Fukuda, Yosuke
    Kashima, Ayaka
    Sagara, Hironori
    INTERNAL MEDICINE, 2023, 62 (13) : 2021 - 2022
  • [24] Identification of atypical ATRNL1 insertion to EML4-ALK fusion gene in NSCLC
    Robesova, Blanka
    Bajerova, Monika
    Hausnerova, Jitka
    Skrickova, Jana
    Tomiskova, Marcela
    Dvorakova, Dana
    LUNG CANCER, 2015, 87 (03) : 318 - 320
  • [25] Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma
    Wang, Qiushi
    Yang, Xin
    He, Yong
    Ma, Qiang
    Lin, Li
    Fu, Ping
    Xiao, Hualiang
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (05): : 515 - 520
  • [26] Localized ALK-positive histiocytosis in a Chinese woman: report of a case in the lung with a novel EML4-ALK rearrangement
    Bai, Yanhua
    Sun, Wei
    Niu, Dongfeng
    Yang, Xin
    Diao, Xinting
    Yu, Yang
    Lin, Dongmei
    VIRCHOWS ARCHIV, 2021, 479 (06) : 1079 - 1083
  • [27] Localized ALK-positive histiocytosis in a Chinese woman: report of a case in the lung with a novel EML4-ALK rearrangement
    Yanhua Bai
    Wei Sun
    Dongfeng Niu
    Xin Yang
    Xinting Diao
    Yang Yu
    Dongmei Lin
    Virchows Archiv, 2021, 479 : 1079 - 1083
  • [28] Real-life experience with Brigatinib in pretreated EML4-ALK translocated NSCLC patients
    Naber, Jakob
    Schwab, Sophia
    Setinek, Ulrike
    Krenbek, Dagmar
    Marcel, Holzer
    Fabikan, Hannah
    Watzka, Stefan
    Koger, Renate
    Fazekase, Andreas
    Bitterlich, Erwin
    Valipour, Arschang
    Burghuber, Otto Chris
    Hochmair, Maximilian Johannes
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 (19-20) : 617 - 618
  • [29] Real-Life Experience with Brigatinib in Pretreated EML4-ALK Translocated NSCLC Patients
    Hochmair, M.
    Naber, J.
    Schwab, S.
    Setinek, U.
    Krenbek, D.
    Holzer, M.
    Fabikan, H.
    Watzka, S.
    Koger, R.
    Fazekas, A.
    Bitterlich, E.
    Valipouni, A.
    Burghuber, O.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S799 - S799
  • [30] Plasma-based diagnostics for detection of EML4-ALK fusion transcripts in NSCLC patients
    Brinkmann, Kay
    Enderle, Daniel
    Koestler, Tina
    Bentink, Stefan
    Emenegger, Jennifer
    Spiel, Alexandra
    Mueller, Romy
    O'Neill, Vincent
    Skog, Johan
    Noerholm, Mikkel
    CANCER RESEARCH, 2015, 75